Latest News about Pablo Zuanic
Recent news which mentions Pablo Zuanic
Mental Health Clinic Poised To Become Leader In A Projected $50B Industry, Analyst Says
December 09, 2022
Tickers
IWINF
From Benzinga
Curaleaf Violated Labor Law By Refusing To Bargain With Union, NLRB Rules, After String Of Unfortunate Events
December 08, 2022
From Benzinga
McConnell Pleased That 'Unrelated Nonsense' Like Cannabis Reform Wasn't In NDAA: What's Next?
December 08, 2022
From Benzinga
Marijuana Banking Reform Not Part Of Defense Bill: No Hope For SAFE Act This Year?
December 07, 2022
From Benzinga
What Makes Upside Potential For Hexo? Analyst Explains On Heels Of The Deal Break With Molson Coors
December 01, 2022
From Benzinga
Why You Should Consider Investing In This Marijuana Stock: One Of Canada's Best Operators, Says Analyst
November 30, 2022
Tickers
OGI
From Benzinga
From Benzinga
How Will NY's Cannabis Rules Impact MSO Market Share In The State? Analyst Shares Industry Update
November 21, 2022
From Benzinga
Aurora Cannabis: What Makes Upside Potential For This Pot Stock? Analyst Has An Idea
November 11, 2022
From Benzinga
Cannabis Earnings Are Flooding In: Here's An Analyst To Help You Digest Them, Four Companies For The Price Of One
November 10, 2022
From Benzinga
Canopy Growth: Analyst Maintains Price Target Of $3.30, Stays Neutral After Q3 Results
November 09, 2022
Tickers
CGC
From Benzinga
From Benzinga
WM Technology: Analyst Lowers Price Target To $5.00 But Stays Overweight
November 08, 2022
Tickers
MAPS
From Benzinga
Cantor Fitzgerald Lowers Price Target On Curaleaf Stock Post Q3 Earnings
November 08, 2022
Tickers
CURLF
From Benzinga
What Happens To Cannabis Bills If Republicans Take House And Senate? Here's One View
November 07, 2022
Tickers
CGC
From Benzinga
Forget About SAFE Plus Or CLIMB Act As Cannabis Stock Catalysts, With Canopy's Potential Exception
November 07, 2022
From Benzinga
Cresco Labs Gains 'Firm Visibility' With Recently Announced Asset Sales To Sean Diddy Combs
November 04, 2022
From Benzinga
Jushi Holdings Will Soon Announce 3Q, Analyst Puts Price Target At $2.25 And Maintains Neutral Rating
November 03, 2022
From Benzinga
Green Thumb Industries' Positive Q3 Report Compels Analyst To Place It Among 'Best-Managed MSOs'
November 03, 2022
From Benzinga
A Big If....Are Multinational Cannabis Companies Interested In Investing in South America?
November 03, 2022
From Benzinga
What's Going On With Recreational Cannabis Sales In Canada? Analyst Examines The Situation
October 31, 2022
From Benzinga
From Benzinga
Germany To Allow Adults To Possess An Ounce Of Cannabis And More In New Legalization Plan
October 26, 2022
From Benzinga
What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus
October 22, 2022
From Benzinga
Analysts Love These 5 Cannabis Stocks
October 20, 2022
From Benzinga
Aurora & Tilray Better Positioned Than Other Cannabis Operators For Germany's Imminent Market Launch, Here's Why
October 20, 2022
From Benzinga
As US Cannabis Sales Decline, This Analyst Predicts More Consolidation – Who Will Benefit?
October 18, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.